linkedin

Our Commitment
We’re committed to making sustainable business decisions for the betterment of society,
global health, and the planet
Samsung Biologics is pursuing its mission to create a better world with high-quality biopharmaceuticals through a global logistics supply chain and comprehensive social responsibilities, while building a basis for sustainability. As a response to climate change, Samsung Biologics will expand its eco-friendly investment in the production facilities and energy reduction in the business sites, while also engaging in the Carbon Disclosure Project (CDP). Moreover, we will grow with the local community through various social contribution activities such as supporting the most vulnerable members of our local community, and fulfilling social environmental responsibilities by participating in the Korea National Institute for Bioprocessing Research & Training (K-NIBRT) to establish the Shared Growth Management.

ESG Report

Sustainability Report 2021
2022 ESG Report
Under the purpose of creating value across economic, societal, and environmental areas and disclosing ESG achievements to the stakeholders in a transparent manner, Samsung Biologics has issued the ESG report. Through the report, we aim to share our annual performances and activities transparently, collect opinions from various stakeholders, and reflect such opinions in our business activities in a bid to enhance the effectiveness of our ESG management practices.
2022 ESG Report
Sustainability Report 2022
Under the purpose of creating value across economic, societal, and environmental areas and disclosing ESG achievements to the stakeholders in a transparent manner, Samsung Biologics has issued the ESG report. Through the report, we aim to share our annual performances and activities transparently, collect opinions from various stakeholders, and reflect such opinions in our business activities in a bid to enhance the effectiveness of our ESG management practices.
Reporting Period
The report covers the period of January 1st, 2021 to December 31st, 2021, but may include significant events dating up to the first half of 2022. Quantitative data for the past three fiscal years from 2019 to 2021 (with some environmental data for four years from 2018 to 2021) has been provided to allow for trend analysis over time.
Reporting Standards
This report was prepared in accordance with the Core option of the Global Reporting Initiative (GRI) standards, global reporting standards for sustainability management. It also used ISO 26000, UN Global Compact principles, Framework, SASB information disclosure standards, and TCFD recommendations as references.
Reporting Scope
This report covers the sustainability activities and performances of all domestic and international businesses. Financial data is based upon consolidated K-IFRS. In addition to financial information, non-financial information has followed our formal disclosure system and has been prepared in accordance with the fiscal year, and the data related to energy usage and greenhouse gas emissions were prepared in accordance with the results of the emission verification.

Marketing Practices

Samsung Biologics endeavors that our marketing activities and materials to promote services and products comply with ethical, medical, and scientific standards as well as applicable laws and regulations. When engaging with healthcare professionals, patients, and business partners, Samsung Biologics will abide by relevant industry standards of conduct.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved